These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

157 related items for PubMed ID: 5375158

  • 1. Effects of mithramycin on Paget's disease of bone.
    Ryan WG, Schwartz TB, Perlia CP.
    Trans Assoc Am Physicians; 1969; 82():353-62. PubMed ID: 5375158
    [No Abstract] [Full Text] [Related]

  • 2. Effects of mithramycin on Paget's disease of bone.
    Ryan WG, Schwartz TB, Perlia CP.
    Ann Intern Med; 1969 Mar; 70(3):549-57. PubMed ID: 5775034
    [No Abstract] [Full Text] [Related]

  • 3. Effects of prolonged thyrocalcitonin administration on Paget's disease of bone.
    Haddad JG, Birge SJ, Avioli LV.
    N Engl J Med; 1970 Sep 10; 283(11):549-55. PubMed ID: 5450609
    [No Abstract] [Full Text] [Related]

  • 4. Treatment of Paget's disease with a diphosphonate (sodium etidronate).
    Smith R, Russell RG.
    Semin Drug Treat; 1972 Sep 10; 2(1):77-81. PubMed ID: 4558759
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Diphosphonates in Paget's disease.
    Russell RG, Smith R, Preston C, Walton RJ, Woods CG.
    Lancet; 1974 May 11; 1(7863):894-8. PubMed ID: 4133419
    [No Abstract] [Full Text] [Related]

  • 7. Mithramycin in Paget's disease.
    Epstein S.
    S Afr Med J; 1974 Jun 09; 48(31):1328-30. PubMed ID: 4276946
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Newer agents in treating Paget's disease of bone.
    Goldfield EB.
    Geriatrics; 1974 Dec 09; 29(12):61-9. PubMed ID: 4279196
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Studies of variations in several biological parameters in Paget's disease (phosphatases, hydroxyproline...) before and after treatment with aspirin].
    Galmiche P, Lévy P.
    Rev Rhum Mal Osteoartic; 1967 Apr 09; 34(4):185-92. PubMed ID: 6059924
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Experiences in the treatment of Paget's disease of bone with mithramycin.
    Ryan WG, Schwartz TB, Northrop G.
    JAMA; 1970 Aug 17; 213(7):1153-7. PubMed ID: 5468261
    [No Abstract] [Full Text] [Related]

  • 14. Role of magnesium metabolism and the effects of fluoride therapy in Paget's disease of bone.
    Avioli LV, Berman M.
    J Clin Endocrinol Metab; 1968 May 17; 28(5):700-10. PubMed ID: 5653203
    [No Abstract] [Full Text] [Related]

  • 15. Control of osteitis deformans using glucagon, calcitonin, and mithramycin.
    Condon JR, Surtees J, Robinson V.
    Postgrad Med J; 1981 Feb 17; 57(664):84-8. PubMed ID: 6455656
    [Abstract] [Full Text] [Related]

  • 16. Paget's disease of bone. Concepts in pathogenesis and treatment with mithramycin.
    Ryan WG.
    Proc Inst Med Chic; 1972 Mar 17; 29(2):81. PubMed ID: 4259573
    [No Abstract] [Full Text] [Related]

  • 17. Treatment of Paget's disease with fluoride.
    Riggs BL, Jowsey J.
    Semin Drug Treat; 1972 Mar 17; 2(1):65-8. PubMed ID: 4558758
    [No Abstract] [Full Text] [Related]

  • 18. Treatment of Paget's disease of bone with mithramycin.
    Condon JR, Reith SB, Nassim JR, Millard FJ, Hilb A, Stainthorpe EM.
    Br Med J; 1971 Feb 20; 1(5746):421-3. PubMed ID: 5543993
    [Abstract] [Full Text] [Related]

  • 19. Paget's disease of bone.
    Smith R.
    J Bone Joint Surg Br; 1995 Sep 20; 77(5):673-4. PubMed ID: 7559686
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.